Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABAergic interneuron-pyramidal neuron pathway is a critical component of neural circuits in the brain, particularly in regions like the neocortex and hippocampus. It involves the interaction between GABAergic interneurons, which are inhibitory neurons releasing the neurotransmitter GABA, and pyramidal neurons, which are excitatory neurons releasing glutamate. This pathway is essential for regulating neural excitability, modulating oscillatory activity, and processing information. Dysregulation of this pathway has been implicated in various neurological disorders.
Modulation of GABA release; Enhancement or reduction of inhibitory postsynaptic potentials (iPSPs); Regulation of neuronal excitability
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GABAergic Interneuron-Pyramidal Neuron Pathway (GABA-IN-PN Pathway).